C. Desgranges

D. Bourboulia, R. Dietze, C. Desgranges, 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection.

S. Muller, J. Briand, C. Desgranges, 2004, Immunity.

Survey of Cutaneous T Cell Lymphomas for Human T-Lymphotropic Virus Infection

Y. Bignon, P. Souteyrand, C. Desgranges, 1994 .

Detection of Epstein-Barr Virus DNA by Nucleic Acid Hybridization

G. Bornkamm, C. Desgranges, S. Wiest, 1985 .

Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties.

J. Dubuisson, C. Wychowski, C. Trépo, 1998, Virology.

Nucleic acid hybridization for the detection of viral genomes.

G. Bornkamm, L. Gissmann, C. Desgranges, 1983, Current topics in microbiology and immunology.

Vasorelaxant effects of grape polyphenols in rat isolated aorta. Possible involvement of a purinergic pathway

C. Desgranges, J. Vercauteren, J. Freslon, 2003, Fundamental & clinical pharmacology.

Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells.

C. Desgranges, A. Gadeau, M. Campan, 1993, The American journal of physiology.

Cell cycle dependent gene expression in quiescent stimulated and asynchronously cycling arterial smooth muscle cells in culture

C. Desgranges, F. Belloc, A. Gadeau, 1992, Journal of cellular physiology.

Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration.

J. Bonnet, M. Renault, C. Desgranges, 2007, Cardiovascular research.

Influence of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) on cell cycle progression and proliferation of cultured arterial smooth muscle cells.

P. Mollard, N. Guérineau, C. Desgranges, 1991, Biochemical pharmacology.

The humanized severe combined immunodeficient mouse as a model for primary human humoral response against HIV1 peptides.

J. Blomberg, C. Desgranges, D. Dye, 1995, Journal of immunological methods.

Effects of angiotensins on cellular hypertrophy and c-fos expression in cultured arterial smooth muscle cells.

O. Costerousse, C. Desgranges, A. Gadeau, 1992, European journal of biochemistry.

Tat-neutralizing versus Tat-protecting antibodies in rhesus macaques vaccinated with Tat peptides.

B. Roques, S. Muller, E. Moreau, 2005, Vaccine.

Targeted expression of HTLV-I envelope proteins in muscle by DNA immunization of mice.

C. Desgranges, D. Paulin, M. Armand, 2000, Vaccine.

YLR209c Encodes Saccharomyces cerevisiae Purine Nucleoside Phosphorylase

B. Daignan-Fornier, M. Konrad, C. Desgranges, 2001, Journal of bacteriology.

Role of adenosine kinase in Saccharomyces cerevisiae: identification of the ADO1 gene and study of the mutant phenotypes

B. Daignan-Fornier, C. Desgranges, I. Belloc, 2001, Yeast.

YLR 209 c Encodes Saccharomyces cerevisiae Purine Nucleoside Phosphorylase

B. Daignan-Fornier, M. Konrad, C. Desgranges, 2001 .

Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord‐blood lymphocytes infected by epstein‐barr virus (EBV)

G. de‐Thé, C. Desgranges, J. Yata, 1975, International journal of cancer.

Frequency of CCR5 gene 32-basepair deletion in Chilean HIV-1 infected and non-infected individuals.

A. Sasco, C. Desgranges, M. Guzmán, 2001, Immunology letters.

A specific one step method for the isolation of pancreatic elastase; its use to characterize aortic elastase.

C. Desgranges, M. Rabaud, H. Bricaud, 1981, Connective tissue research.

Time Course of Osteopontin, Osteocalcin, and Osteonectin Accumulation and Calcification After Acute Vessel Wall Injury

D. Daret, C. Desgranges, M. Kockx, 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Extracellular Nucleotides Induce Arterial Smooth Muscle Cell Migration Via Osteopontin

P. Pacaud, M. Renault, C. Desgranges, 2001, Circulation research.

Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus.

J. Edwards, G. de Thé, C. Desgranges, 1984, The Journal of infectious diseases.

beta-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent beta2 component in pulmonary hypertension.

H. Bégueret, N. Bellance, C. Desgranges, 2008, Cardiovascular research.

β-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent β2 component in pulmonary hypertension

H. Bégueret, N. Bellance, C. Desgranges, 2007 .

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells.

M. Kieny, C. Dauguet, S. Muller, 1993, AIDS research and human retroviruses.

Detection of Epstein‐Barr viral DNA internal repeats in the nasopharyngeal mucosa of chinese with IgA/ebv‐specific antibodies

G. de‐Thé, C. Desgranges, Y. Zeng, 1982, International journal of cancer.

Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.

D. Smadja, A. Vahlne, C. Desgranges, 1994, AIDS research and human retroviruses.

A synthetic HIV‐1 Tat protein breaches the skin barrier and elicits Tat‐neutralizing antibodies and cellular immunity

S. Muller, E. Moreau, J. Briand, 2004, European journal of immunology.

CREB Mediates UTP-Directed Arterial Smooth Muscle Cell Migration and Expression of the Chemotactic Protein Osteopontin via Its Interaction with Activator Protein-1 Sites

M. Renault, C. Desgranges, S. Jalvy, 2007, Circulation research.

Nucleotide Receptors Involved in UTP-Induced Rat Arterial Smooth Muscle Cell Migration

X. Pillois, C. Desgranges, A. Gadeau, 2002, Circulation research.

Nucleotide receptor P2u partially mediates ATP‐induced cell cycle progression of aortic smooth muscle cells

P. Pacaud, X. Pillois, C. Desgranges, 1996, Journal of cellular physiology.

Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor.

M. Peyot, C. Desgranges, A. Gadeau, 2000, Circulation research.

EBV specific secretory IgA in saliva of NPC patients. Presence of secretory piece in epithelial malignant cells

G. de‐Thé, C. Desgranges, J. Y. Li, 1977, International journal of cancer.

Human monoclonal antibodies with a protective activity against tetanus toxin

C. Desgranges, M. Trabaud, L. Léry, 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients.

W. Martin, J. Tugwood, J. Arrand, 1987, The Journal of general virology.

infected peripheral blood memory B cells Functional Epstein-Barr virus reservoir in plasma cells derived from

G. Petitjean, V. Foulongne, C. Desgranges, 2014 .

Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.

J. Seigneurin, G. Petitjean, V. Foulongne, 2009, Blood.

Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals.

A. Romieu, B. Roques, J. Zagury, 2003, Vaccine.

7-Ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swelling.

A. Herman, M. Knaapen, D. Daret, 2004, Cardiovascular research.

Induction of neutralizing antibodies against HTLV-I envelope proteins after combined genetic and protein immunizations in mice.

C. Desgranges, M. Armand, G. Audoly, 1997, DNA and cell biology.

Semiquantitative analysis of residual disease in patients treated for adult T‐cell leukaemia/lymphoma (ATLL)

E. Wattel, I. Leclercq, M. Cavrois, 1999, British journal of haematology.

Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles

F. Jensen, M. Deckert, A. Bernard, 1997, Journal of virology.

Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides.

S. Muller, E. Moreau, C. Partidos, 2004, The Journal of general virology.

In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate).

D. Schmitt, C. Desgranges, J. Thivolet, 1993, Research in virology.

In vitro HIV-1 entry and replication in Langerhans cells may clarify the HIV-1 genome detection by PCR in epidermis of seropositive patients.

D. Schmitt, F. Mallet, C. Desgranges, 1992, The Journal of investigative dermatology.

Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV‐1 infected patients with tropical spastic paraparesis

C. Confavreux, M. Belin, P. Giraudon, 1998, Neurology.

Human and murine monoclonal antibodies directed against a conserved sequence from gp41 (aa583-599) of human immunodeficiency virus type 1.

J. Blomberg, R. Pipkorn, P. Klasse, 1992, Research in virology.

DNA Polymerases of Anucleated Cells

C. Desgranges, L. Tarrago-Litvak, S. Litvak, 1979 .

Langerhans Cells and HIV Infection

D. Schmitt, C. Tsagarakis, F. Mallet, 1995 .

Presence of EBV‐DNA sequences in nasopharyngeal cells of individuals without IgA‐VCA antibodies

G. Bornkamm, G. de‐Thé, C. Desgranges, 1983, International journal of cancer.

MONOCLONAL ANTIBODIES TO HIV IN A NON-INFECTED, IMMUNISED VOLUNTEER

R. Gallo, C. Desgranges, D. Zagury, 1988, The Lancet.

ATP raises [Ca2+]i via different P2-receptor subtypes in freshly isolated and cultured aortic myocytes.

P. Pacaud, C. Desgranges, G. Loirand, 1995, The American journal of physiology.

Transfusion transmission of human T‐lymphotropic virus type I (HTLV‐I) from an asymptomatic blood donor: conservation of LTR U3, env, and tax nucleotide sequences in a recipient with HTLV‐I‐associated myelopathy

C. Desgranges, M. D’Incan, M. Gasmi, 1997, Transfusion.

Establishment of T-lymphoid cell lines from Morroccan patients with tropical spastic paraparesis.

N. Noraz, C. Desgranges, A. Benslimane, 1992, AIDS research and human retroviruses.

Activation of the lytic program of the Epstein-Barr virus in Burkitt's lymphoma cells leads to a two steps downregulation of expression of the proapoptotic protein BimEL, one of which is EBV-late-gene expression dependent.

A. Vazquez, I. Joab, C. Desgranges, 2009, Virology.

Persistence of human adenovirus 5 in human cord blood lymphoblastoid cell lines transformed by Epstein-Barr virus.

C. Desgranges, N. Faucon, C. Des̀granges, 1980, Infection and immunity.

Complement Receptor Type 2 Mediates Infection of the Human CD4‐Negative Raji B‐Cell Line with Opsonized HIV

M. Kazatchkine, N. Noraz, C. Desgranges, 1992, Scandinavian journal of immunology.

The Role of Complement in Enhancing Infection of Target Cells with Human Immunodeficiency Virus

M. Kazatchkine, C. Desgranges, N. Thieblemont, 1993 .

Purification of human alpha 1 antiprotease-pancreatic elastase complex. Interaction with homologous elastin.

C. Desgranges, M. Rabaud, H. Bricaud, 1984, Connective tissue research.

(E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity.

E. De Clercq, C. Desgranges, R. Bernaerts, 1989, Biochemical pharmacology.

Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.

E. De Clercq, P. Herdewijn, J. Balzarini, 1986, Cancer research.

Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets.

E. De Clercq, J. Balzarini, C. Desgranges, 1983, Biochemical pharmacology.

The Role of Nucleotide Receptors in the Cardiovascular System

G. Vassort, S. Pirotton, J. Boeynaems, 1998 .

Deoxyribosyl exchange reactions leading to the in vivo generation and regeneration of the antiviral agents (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5-ethyl-2'-deoxyuridine and 5-(2-chloroethyl)-2'-deoxyuridine.

E. De Clercq, C. Desgranges, H. Bricaud, 1986, Biochemical pharmacology.

Toxicity and activity of purified trichosanthin.

E. Mandine, P. Smets, R. Zalisz, 1991, AIDS.

Complement‐dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV‐I)‐infected cells in the sera of HTLV‐I‐infected individuals

C. Desgranges, J. Vernant, H. PLOTNI CKY‐GILQUIN, 1996, Clinical and experimental immunology.

Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non‐tumorous tissues of chinese patients with special reference to lymphoblastoid transformation

G. de‐Thé, C. Desgranges, H. C. Kwan, 1970, International journal of cancer.

Separation of human lymphocytes forming spontaneous rosettes with sheep erythrocytes.

G. de Thé, C. Desgranges, J. Yata, 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.

E. De Clercq, P. Herdewijn, C. Desgranges, 1984, Nucleic acids research.

Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.

R. T. Walker, E. De Clercq, P. Herdewijn, 1986, Journal of medicinal chemistry.

The human blood platelet: a cellular model to study the degradation of thymidine and its inhibition.

C. Desgranges, M. Rabaud, H. Bricaud, 1982, Biochemical pharmacology.

High affinity human monoclonal antibodies directed against hepatitis B surface antigen.

C. Desgranges, J. Paire, C. Pichoud, 1987, Journal of virological methods.

Inhibition and reversal of the degradation of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo

E. Clercq, C. Desgranges, H. Bricaud, 1985 .

Inhibition of the degradation of thymine and 5-substituted uracil analogues by (E)-5-(2-bromovinyl)uracil in vivo

E. Clercq, C. Desgranges, H. Bricaud, 1985 .

Therapeutic Implications of the Unusually Long Half-Life of (E)-5-(2-BRO-Movinyl)Uracil (BVUra) in Vivo

E. Clercq, C. Desgranges, G. Razaka, 1985 .

Generation and Characterization of Neutralizing Human Monoclonal Antibodies against Human Immunodeficiency Virus Type 1 Tat Antigen

Claude Desgranges, Johan Hoebeke, S. Muller, 2004, Journal of Virology.

Comparison between direct binding, competition and agglutination assays in the characterization of polyclonal anti-idiotypes against anti-HBs human monoclonal antibodies.

C. Desgranges, J. Grange, M. Trabaud, 1993, Journal of immunological methods.

Characterization and large production of human monoclonal antibodies against the HIV‐1 envelope

J. Rossier, H. Broly, C. Desgranges, 1991, Clinical and experimental immunology.

Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans

C. Desgranges, K. Brahimi, Y. Charoenvit, 1990, Infection and immunity.

Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM.

C. Dupont, M. Bomsel, H. Hocini, 1998, Immunity.

Bromovinyluracil nucleoside analogues as antiherpes agents

R. T. Walker, P. Herdewijn, C. Desgranges, 1984 .

IgM antibodies directed to HIV: the neglected issue?

A. Burny, P. Van de Perre, C. Desgranges, 1994, AIDS research and human retroviruses.

Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion

M. Kazatchkine, C. Desgranges, V. Boyer, 1991, The Journal of experimental medicine.

Production and characterization of a monoclonal antibody directed against HTLV-1 p19: use in a specific capture enzyme immunoassay.

N. Noraz, C. Desgranges, J. Grange, 1993, Hybridoma.

The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction

S. Muller, B. Masquida, S. Muller, 2005, Cellular and Molecular Life Sciences CMLS.

Neutralizing EBV‐specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients

G. de‐Thé, R. Ellouz, C. Desgranges, 1977, International journal of cancer.

Epstein‐barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomas

G. de‐Thé, C. Desgranges, C. Des̀granges, 1979, International journal of cancer.

Comparative evaluation of various techniques to detect EBV DNA in exfoliated nasopharyngeal cells

G. Bornkamm, G. de‐Thé, C. Desgranges, 1983 .

Nasopharyngeal carcinoma. VII. B and T lymphocytes in the circulating blood and in tumour tissue.

G. de‐Thé, R. Ellouz, J. Brugère, 1974, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Inhibitory control of TGF‐β1 on the activation of Rap1, CD11b, and transendothelial migration of leukocytes

E. Génot, M. Perretti, D. Davies, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty.

T. Couffinhal, C. Duplàa, J. Bonnet, 1993, International journal of cardiology.

Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.

E. Karita, P. Lepage, C. Trépo, 1999, The Journal of infection.

The binding affinity of double‐stranded RNA motifs to HIV‐1 Tat protein affects transactivation and the neutralizing capacity of anti‐Tat antibodies elicited after intranasal immunization

Claude Desgranges, Johan Hoebeke, S. Muller, 2005, European journal of immunology.

Primary in vitro immunization with multimeric synthetic peptides of HIV-1 envelope glycoproteins: generation of neutralizing human monoclonal antibodies.

J. Blomberg, C. Fraisier, C. Desgranges, 1994, Journal of immunological methods.

Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.

F. Lucht, B. Pozzetto, C. Desgranges, 2000, The Journal of infectious diseases.

Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression.

J. Thèze, C. Desgranges, D. Goossens, 1995, Immunology letters.

Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins.

M T Hearn, I Cosic, I. Cosic, 2009, The journal of peptide research : official journal of the American Peptide Society.

HIV-1 Tat and Apoptotic Death

S. Muller, C. Desgranges, C. Des̀granges, 2005 .

In vitro HIV-1 infection of isolated epidermal Langerhans cells with a cell-free system.

D. Schmitt, F. Mallet, C. Desgranges, 1995, Advances in experimental medicine and biology.

Identification of exposed epitopes on the envelope glycoproteins of human T‐cell lymphotropic virus type I (HTLV‐I)

A. Rosenberg, C. Desgranges, P. Horal, 1998, International journal of cancer.

Presence of HIV-1 subtypes B and F and HTLV-I in HIV/HTLV coinfected individuals of Martinique.

R. Césaire, S. Fillon, C. Desgranges, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.

M. Bonneville, J. Moreau, J. Soulillou, 1986, The Journal of clinical investigation.

Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein.

S. Muller, M. Jolivet, J. Briand, 2002, Journal of molecular biology.

HTLV‐I‐associated lymphoma presenting as mycosis fungoides in an HTLV‐I non‐endemic area: a viro‐molecular study

P. Souteyrand, C. Desgranges, M. D’Incan, 1995, The British journal of dermatology.

Lack of correlation between human T-lymphotropic virus type I DNA integration and clinical course of adult T-cell leukemia/lymphoma.

P. Souteyrand, C. Desgranges, M. D’Incan, 1995, Blood.

Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.

S. Benichou, N. Noraz, C. Desgranges, 1993, Virology.

Detection of HTLV-1 DNA by polymerase chain reaction in alveolar lymphocytes of patients with tropical spastic paraparesis.

C. Desgranges, L. Couderc, J. Vernant, 1989, The Journal of infectious diseases.

Glomerulonephritis in common marmosets infected with Plasmodium brasilianum and Epstein-Barr virus.

G. de Thé, C. Desgranges, G. Mitchell, 1988, The Journal of infectious diseases.

Epstein-Barr virus-transformed lymphocytes from patients with bullous diseases produce autoantibodies to cytokeratins.

C. Desgranges, J. Paire, K. Iwatsuki, 1986, Clinical immunology and immunopathology.

Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta.

D. Daret, C. Desgranges, A. Gadeau, 1997, Arteriosclerosis, thrombosis, and vascular biology.

IgA and nasopharyngeal carcinoma.

G. de‐Thé, C. Desgranges, 1978, IARC scientific publications.

EPSTEIN-BARR VIRUS INDUCES VIRAL NUCLEAR ANTIGEN IN NASOPHARYNGEAL EPITHELIAL CELLS

G. de‐Thé, C. Desgranges, C. Des̀granges, 1977, The Lancet.

HIV-1 subtypes in Santiago, Chile.

S. Fillon, C. Desgranges, F. Letourneur, 1998, AIDS.

Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro.

T. Candresse, C. Desgranges, A. Gadeau, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Broadly neutralizing, MN-like PND-directed antibodies in Rwandan children with long-term HIV1 infection.

E. Karita, C. Fraisier, P. Lepage, 1995, Research in virology.

Screening for HTLV-I

C. Desgranges, M. Contreras, J. Barbara, 1990, The Lancet.

Herpes simplex-RAJI(A44), a new cell line for serologic testing by immunofluorescence.

J. Seigneurin, G. de‐Thé, C. Desgranges, 1976, Journal of immunology.

In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains.

G. de‐Thé, C. Desgranges, J. Patet, 1979, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes.

G. Lenoir, J. Seigneurin, G. de‐Thé, 1976, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Kaposi's sarcoma and HTLV-I infection

C. Veyssier-Belot, C. Desgranges, L. Couderc, 1990, The Lancet.

Characterization andlarge production ofhuman monoclonal antibodies against theHIV-1envelope

H. Broly, C. Desgranges, V. Boyer, 1991 .

The potential impact of CD4+ T cell activation and enhanced Th1/Th2 cytokine ratio on HIV-1 secretion in the lungs of individuals with advanced AIDS and active pulmonary infection.

P. Van de Perre, N. Nagot, A. Bourdin, 2011, Clinical immunology.

Lymphocytes in infectious mononucleosis. Properties of atypical cells and origin on the lymphoblastoid lines.

G. de Thé, C. Desgranges, J. Yata, 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Design and Intracellular Activity of a Human Single-Chain Antibody to Human Immunodeficiency Virus Type 1 Conserved gp41 Epitope

I. Legastelois, C. Desgranges, C. Des̀granges, 2000, Journal of Virology.

PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES AGAINST ASEXUAL ERYTHROCYTIC STAGES OF PLASMODIUM FALCIPARUM

A. Karabinis, C. Desgranges, L. Monjour, 1983, The Lancet.

Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses.

B. Verrier, N. Noraz, C. Fraisier, 1995, AIDS research and human retroviruses.

In vitro analysis of complement-dependent HIV-1 cell infection using a model system.

Robert B Sim, N. Thielens, P. Tacnet-Delorme, 1999, Journal of immunology.

HIV-1 Cell Infection Using a Model System In Vitro Analysis of Complement-Dependent

Claude Desgranges, Jean-François Hernandez, Isabelle Bally, 2013 .

Magnesium enhances human pancreatic elastase digestion of125I-labeled elastin

C. Desgranges, M. Rabaud, H. Bricaud, 1985, Experientia.

P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.

P. Pacaud, C. Desgranges, A. Gadeau, 2000, American journal of physiology. Heart and circulatory physiology.

Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients.

C. Desgranges, M. D’Incan, M. Gasmi, 1994, AIDS research and human retroviruses.

Antibodies to HTLV-I in Sjögren's syndrome

X. Mariette, L. Bélec, D. Cazals, 1995, The Lancet.